| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-18 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.31 | 4e-16 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-15 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.3 | 3e-15 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.29 | 4e-15 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.29 | 3e-13 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.27 | 7e-13 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.41 | 1e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-12 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-12 |